UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Review article: remission rates achievable by current therapies for inflammatory bowel disease

Alimentary pharmacology & therapeutics, 2011-04, Vol.33 (8), p.870-879

2011

Volltextzugriff (PDF)

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management

Journal of Crohn's & colitis, 2010-02, Vol.4 (1), p.28-62

2010

Volltextzugriff (PDF)

Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry

Annals of the rheumatic diseases, 2011-04, Vol.70 (4), p.616-623

2011

Volltextzugriff (PDF)

Predicting the need for colectomy in severe ulcerative colitis: a critical appraisal of clinical parameters and currently available biomarkers

Gut, 2011-01, Vol.60 (1), p.3-9

2011

Volltextzugriff (PDF)

European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

Journal of Crohn's and colitis, 2009-06, Vol.3 (2), p.47-91

2009

Volltextzugriff (PDF)

The efficacy and safety of a third anti‐TNF monoclonal antibody in Crohn’s disease after failure of two other anti‐TNF antibodies

Alimentary pharmacology & therapeutics, 2010-01, Vol.31 (1), p.92-101

2010

Volltextzugriff (PDF)

European evidence-based Consensus on the management of ulcerative colitis: Current management

Journal of Crohn's and colitis, 2008-03, Vol.2 (1), p.24-62

2008

Volltextzugriff (PDF)

Lymphoma in patients treated with anti-TNF: results of the 3-year prospective French RATIO registry

Annals of the rheumatic diseases, 2010-02, Vol.69 (2), p.400-408

2010

Volltextzugriff (PDF)

Review article: can post‐operative recurrence in Crohn's disease be prevented?

Alimentary Pharmacology and Therapeutics, 2006-10, Vol.24 (s3), p.22-28

Lemann, M

2006

Volltextzugriff (PDF)

Distinct eosinophil cytokine expression patterns in skin diseases – the possible existence of functionally different eosinophil subpopulations

Allergy (Copenhagen), 2011-11, Vol.66 (11), p.1477-1486

2011

Volltextzugriff (PDF)

European evidence based consensus on the diagnosis and management of Crohn’s disease: current management

Gut, 2006-03, Vol.55 (suppl 1), p.i16-i35

2006

Volltextzugriff (PDF)

Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine

Gut, 2007-10, Vol.56 (10), p.1404-1409

2007

Volltextzugriff (PDF)

Emergence of Legionella pneumophila Pneumonia in Patients Receiving Tumor Necrosis Factor–α Antagonists

Clinical infectious diseases, 2006-11, Vol.43 (10), p.e95-e100

2006

Volltextzugriff (PDF)

An open‐label study of thalidomide for maintenance therapy in responders to infliximab in chronically active and fistulizing refractory Crohn's disease

Alimentary pharmacology & therapeutics, 2002-06, Vol.16 (6), p.1117-1124

2002

Volltextzugriff (PDF)

Development and validation of a patient‐reported disability measurement tool for patients with inflammatory bowel disease

Alimentary Pharmacology & Therapeutics (Suppl), 2013-02, Vol.37 (4), p.438-444

2013

Volltextzugriff (PDF)

Comparison of a low dose polyethylene glycol electrolyte solution with lactulose for treatment of chronic constipation

Gut, 1999-02, Vol.44 (2), p.226-230

1999

Volltextzugriff (PDF)

Cronkhite-Canada syndrome

Annales de dermatologie et de vénéréologie, 2007-08, Vol.134 (8-9), p.709-710

2007

Volltextzugriff (PDF)

TNFSF15 Polymorphisms Are Associated With Susceptibility to Inflammatory Bowel Disease in a New European Cohort

The American journal of gastroenterology, 2009-02, Vol.104 (2), p.384-391

2009

Volltextzugriff (PDF)

Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn’s disease: a randomised, double blind, placebo controlled GETAID trial

Gut, 2006-06, Vol.55 (6), p.842-847

2006

Volltextzugriff (PDF)

Long-term follow-up of patients with tuberculosis as a complication of tumour necrosis factor (TNF)-α antagonist therapy: safe re-initiation of TNF-α blockers after appropriate anti-tuberculous treatment

Clinical microbiology and infection, 2008-02, Vol.14 (2), p.183-186

2008

Volltextzugriff (PDF)

A first case report of a patient with paraneoplastic dermatomyositis developing diffuse alveolar haemorrhage

British journal of dermatology (1951), 2010-07, Vol.163 (1), p.227-228

2010

Volltextzugriff (PDF)

Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped

Gastroenterology (New York, N.Y. 1943), 2012, Vol.142 (1), p.63-70.e5

2012

Volltextzugriff (PDF)

Questions to Pr Lémann

Gastroentérologie clinique et biologique, 2008-05, Vol.32 (5 Pt 1), p.486-488

Lémann, M

2008

Volltextzugriff (PDF)

Infliximab for refractory ulcerative colitis or indeterminate colitis: an open‐label multicentre study

Alimentary pharmacology & therapeutics, 2003-07, Vol.18 (2), p.175-181

2003

Volltextzugriff (PDF)

Successive Treatment With Cyclosporine and Infliximab in Steroid-Refractory Ulcerative Colitis

The American journal of gastroenterology, 2011-04, Vol.106 (4), p.771-777

2011

Volltextzugriff (PDF)

1 – 25 von 350

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(256)
Mit Volltextzugriff
(241)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(194)
Science & Technology
(167)
Life Sciences & Biomedicine
(163)
Female
(114)
Adult
(113)
Male
(110)
Gastroenterology & Hepatology
(107)
Biological And Medical Sciences
(91)
Medical Sciences
(86)
Middle Aged
(66)
Aged
(36)
Gastroenterology. Liver. Pancreas. Abdomen
(36)
Adolescent
(35)
Other Diseases. Semiology
(30)
Stomach. Duodenum. Small Intestine. Colon. Rectum. Anus
(30)
Treatment Outcome
(30)
Crohn Disease - Drug Therapy
(29)
Pharmacology. Drug Treatments
(27)
Immunosuppressive Agents - Therapeutic Use
(25)
Infliximab
(24)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Review article: remission rates achievable by current therapies for inflammatory bowel disease

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management

Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry

Predicting the need for colectomy in severe ulcerative colitis: a critical appraisal of clinical parameters and currently available biomarkers

European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

The efficacy and safety of a third anti‐TNF monoclonal antibody in Crohn’s disease after failure of two other anti‐TNF antibodies

European evidence-based Consensus on the management of ulcerative colitis: Current management

Lymphoma in patients treated with anti-TNF: results of the 3-year prospective French RATIO registry

Review article: can post‐operative recurrence in Crohn's disease be prevented?

Distinct eosinophil cytokine expression patterns in skin diseases – the possible existence of functionally different eosinophil subpopulations

European evidence based consensus on the diagnosis and management of Crohn’s disease: current management

Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine

Emergence of Legionella pneumophila Pneumonia in Patients Receiving Tumor Necrosis Factor–α Antagonists

An open‐label study of thalidomide for maintenance therapy in responders to infliximab in chronically active and fistulizing refractory Crohn's disease

Development and validation of a patient‐reported disability measurement tool for patients with inflammatory bowel disease

Comparison of a low dose polyethylene glycol electrolyte solution with lactulose for treatment of chronic constipation

Cronkhite-Canada syndrome

TNFSF15 Polymorphisms Are Associated With Susceptibility to Inflammatory Bowel Disease in a New European Cohort

Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn’s disease: a randomised, double blind, placebo controlled GETAID trial

Long-term follow-up of patients with tuberculosis as a complication of tumour necrosis factor (TNF)-α antagonist therapy: safe re-initiation of TNF-α blockers after appropriate anti-tuberculous treatment

A first case report of a patient with paraneoplastic dermatomyositis developing diffuse alveolar haemorrhage

Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped

Questions to Pr Lémann

Infliximab for refractory ulcerative colitis or indeterminate colitis: an open‐label multicentre study

Successive Treatment With Cyclosporine and Infliximab in Steroid-Refractory Ulcerative Colitis

Suchergebnisse filtern